Literature DB >> 8852548

Emergence of ciprofloxacin resistance during treatment of Salmonella osteomyelitis in three patients with sickle cell disease.

M R Workman1, J Philpott-Howard, S Bragman, F Brito-Babapulle, A J Bellingham.   

Abstract

The treatment of salmonella osteomyelitis in sickle cell disease (SCD) is difficult and the emergence of antibiotic resistance in Salmonella spp presents further problems for clinicians treating SCD. Three patients presented with salmonella bacteraemia. Treatment with several intravenous antibiotics did not prevent the subsequent development of osteomyelitis. Emergence of resistance to multiple antibiotics, including ciprofloxacin, during the treatment of salmonella osteomyelitis in SCD patients is reported here for the first time. Ceftriaxone 2 g once daily given for 3 months to 3 years was an effective and convenient treatment for osteomyelitis caused by multiply-resistant salmonella. Two of these patients gave a definite history of diarrhoea, and stool cultures confirmed the presence of Salmonella spp in one. Our experience shows that salmonella osteomyelitis may not be prevented by early treatment of bacteraemia in SCD patients. Other measures to reduce the risk of salmonella infection are therefore necessary.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8852548     DOI: 10.1016/s0163-4453(96)80006-5

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  9 in total

Review 1.  Osteoblast responses to bacterial pathogens: a previously unappreciated role for bone-forming cells in host defense and disease progression.

Authors:  Ian Marriott
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

2.  Managing patients with an absent or dysfunctional spleen. Guidelines should highlight risk of Salmonella infection in sickle cell disease.

Authors:  M R Workman; J Philpott-Howard; A J Bellingham
Journal:  BMJ       Date:  1996-05-25

Review 3.  Prevention and management of infection in children with sickle cell anaemia.

Authors:  W Y Wong
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

4.  Induction of colony-stimulating factor expression following Staphylococcus or Salmonella interaction with mouse or human osteoblasts.

Authors:  K L Bost; J L Bento; J K Ellington; I Marriott; M C Hudson
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

5.  Bacterium-induced CXCL10 secretion by osteoblasts can be mediated in part through toll-like receptor 4.

Authors:  Nancy A Gasper; Cynthia C Petty; Laura W Schrum; Ian Marriott; Kenneth L Bost
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

6.  Osteoblasts express NLRP3, a nucleotide-binding domain and leucine-rich repeat region containing receptor implicated in bacterially induced cell death.

Authors:  Samuel H McCall; Mahnaz Sahraei; Amy B Young; Charles S Worley; Joseph A Duncan; Jenny Pan-Yun Ting; Ian Marriott
Journal:  J Bone Miner Res       Date:  2008-01       Impact factor: 6.741

7.  Non-typhoid salmonella septic arthritis in dual living liver transplant recipient: a case report.

Authors:  Kun Moo Choi; Cheon Soo Park; Gi-Won Song; Sung-Gyu Lee
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2014-02-24

Review 8.  Apoptosis-associated uncoupling of bone formation and resorption in osteomyelitis.

Authors:  Ian Marriott
Journal:  Front Cell Infect Microbiol       Date:  2013-12-19       Impact factor: 5.293

Review 9.  Acute Hematogenous Osteomyelitis in Children: Clinical Presentation and Management.

Authors:  J Chase McNeil
Journal:  Infect Drug Resist       Date:  2020-12-14       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.